LOGIN

China issues 2021 national reimbursement drugs list, three key trends...

Yearly Archives: 2021

Default Image

China issues 2021 national reimbursement drugs list, three key trends…

  • 23 December 2021
Read More
Default Image

Build Back Better could set new precedent for US drug pricing controls

  • By Margaret Labban, PhD
  • 3 December 2021
Read More
Default Image

10 steps for a successful market access strategy

  • 20 September 2021
Read More

Strategies to mitigate global price and revenue erosion within hemophilia

  • 14 September 2021
Read More
Default Image

GPI horizon, the price forecasting methodology that is transforming market access strategy

  • 27 August 2021
Read More

“It’s Time For A Prescription Drug Pricing Revolution…”

  • 6 August 2021
Read More

Identifying the relative clinical positioning in core EU markets

  • 26 July 2021
Read More

Net price forecasting and launch optimisation for an IO asset on UK oncology indication expansion for top tier pharmaceutical

  • 16 June 2021
Read More

GPI horizon representing disruptive innovation in the consulting industry

  • 27 May 2021
Read More

Early Pricing and Market Access Forecasting for Orphan Assets

  • By Eva Barkhauskaite, Rachel Jao, Preeti Patel and Tom Brockbank
  • 20 May 2021
Read More

Previous Posts

Stay Informed

Sign up to receive the latest news and trends
straight into your inbox from GPI